Why Constellation Software Stock Is a Must Buy Ahead of Earnings

Constellation (TSX:CSU) stock has earnings coming out soon and continues to make some strong acquisitions, with management announcing big plans for 2022.

Constellation Software (TSX: CSU) is one of the strongest tech companies you can own on the TSX today. The company’s management has proven again and again that it can identify software companies that will bring in even more revenue.

But lately, shares of Constellation stock have seen slower growth. So, ahead of earnings, should investors see this share performance as a red flag or a buying opportunity?

What to expect

Constellation stock will release earnings on May 4. That’s just about two weeks away as of writing, giving you enough time to make some decisions surrounding the stock.

Honestly, analysts haven’t had much to say. And that’s actually a good thing. Constellation has been incredibly solid with its revenue growth, and that comes from a strategy that’s proven itself time and again.

This strategy mainly surrounds finding niche software companies, buying them, providing resources, and seeing them flourish. It owns everything from subway operations to library tech services. And that hasn’t slowed down at all, pandemic or not.

An exciting new buy

Now as I said, acquisitions are normal for the company. Back in March, Constellation stock announced the purchase of a medical records software company based out of Chicago. Allscripts Healthcare Solutions was purchased for US$700 million in cash and stock.

What makes the buy different? It’s in the medical industry. This industry demands an overhaul, especially here in Canada, with the use of telehealth becoming more mainstream. Allscripts’s business focuses on hospitals and larger physician practices. Its software is needed for everything from record keeping to billing.

It’s one of the first acquisitions Chief Executive Officer Mark Leonard has made after stating his company would focus on larger acquisitions, as it has so much cash on hand. Constellation stock spent US$1.2 billion in 2021 alone and is already well past the halfway point with this one purchase. With healthcare such a strong investment to make, this could create a massive opportunity for growth-minded investors.

What now?

When earnings come out, we hope to see a sneak peek at what the company expects from this latest acquisition. Furthermore, we should also see performance from those acquisitions made last year of over US$1 billion. During the last quarter, Constellation stock brought in US$1.38 billion in revenue and profit of US$145 million.

The thing is, Canadians still don’t consider this stock a screaming buy. Why? It’s likely the share price. It remains in the $2,000 range and will only continue up from there. While a stock split is never off the table, it doesn’t look like management will be announcing one anytime soon. But that shouldn’t put off investors who want solid returns from this stable tech stock.

As for now, investors buying Constellation stock can pick it up down 9% from 52-week highs. It offers a 0.23% dividend yield of $5.06 per share. Shares are up 20% in the last year and 240% over the last five years.

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Constellation Software.

More on Tech Stocks

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

Where Could Celestica Stock Be in 5 Years? What the New Outlook Means

Celestica’s ambitious 2027 outlook and accelerating AI infrastructure demand could fuel its next phase of growth, making its recent stock…

Read more »

A person uses and AI chat bot
Tech Stocks

This Canadian Tech Stock Is a Steal, and I’m Telling New Investors to Buy It Right Now

A beaten-down share price, growing cloud business, and AI-focused initiatives make this Canadian tech stock attractive for new investors seeking…

Read more »

frustrated shopper at grocery store
Tech Stocks

Shopify Stock Is Down 16% in the Past Month: Should You Buy the Dip?

Shopify stock fell 16% recently. Discover the impact of interest rate hikes and market sentiment on Shopify's performance.

Read more »

scanning a package shipping label for ecommerce delivery
Tech Stocks

Shopify After the Selloff: What Would Make Me Buy, Hold, or Wait?

Shopify’s latest quarter showed a fast-growing business. My buy decision depends on how much of that growth the price already…

Read more »

Digital background depicting innovative technologies in (AI) artificial systems, neural interfaces and internet machine learning technologies
Tech Stocks

Celestica Raised Its 2027 Outlook After Sales Jumped 83%: Is It Too Late to Buy?

With revenue expected to grow 90% in 2027 and adjusted EPS projected to increase 86%, Celestica’s growth prospects remain compelling.

Read more »

atomic particle
Tech Stocks

Constellation Software in a TFSA: Great Business, but Is the Price Right?

Constellation’s acquisition engine appeals, while a cash-flow valuation check argues for patience.

Read more »

Close up of an egg in a nest of twigs on grass with RRSP written on it symbolizing a RRSP contribution.
Dividend Stocks

The RRSP Deadline Is in March: Why Starting in November Gives You the Advantage

Many investors hold stocks like Shopify Inc (TSX:SHOP) in their RRSPs.

Read more »

man studies at computer
Dividend Stocks

Here Are The 3 Canadian Stocks I’d Tell a New Investor to Buy ASAP

Discover strategies for investing in stocks that can help you thrive in a market filled with volatility and uncertainty.

Read more »